COMMUNIQUÉS West-GlobeNewswire
-
Guerbet : 2025 revenue.
05/02/2026 -
Cross Medical Group Announces New Villanova Office Location
05/02/2026 -
Virbac : Declaration of the number of shares and voting rights 01/2026
05/02/2026 -
Thought Leadership & Innovation Foundation Announces Bill Oldham’s Appointment to the NIH Interagency Autism Coordinating Committee
05/02/2026 -
Novo Nordisk issues statement on illegal mass compounding and deceptive advertising by Hims & Hers
05/02/2026 -
Introducing Community by Keto-Mojo – A Supportive, Expert-Led Space to Help People Succeed in Ketosis and Beyond
05/02/2026 -
Blueprint for Action Calls for Pan-Canadian Leadership to Close the Women’s Health Gap
05/02/2026 -
Le plan d’action Diriger pour combler l’écart demande aux acteurs au pouvoir partout au pays de réduire les disparités en matière de santé des femmes
05/02/2026 -
Virbac : Déclaration d'actions et de droits de vote 01/2026
05/02/2026 -
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies
05/02/2026 -
Serotonin Anti-Aging Center to Open Lake Nona Location This Spring, Expanding Orlando Presence
05/02/2026 -
Akari Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
05/02/2026 -
Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program
05/02/2026 -
Moleculin to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
05/02/2026 -
GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
05/02/2026 -
NDT Pharmaceuticals Inc.’s Wholly Owned Subsidiary, Good Salt Life, Receives Official Green Seal® Certification for Clean Republic Multipurpose Disinfectant
05/02/2026 -
ADARx Pharmaceuticals Appoints Donald Fong, M.D., as Chief Medical Officer
05/02/2026 -
Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
05/02/2026 -
Propanc Biopharma Unveils PRP: A Game-Changing Proenzyme Therapy Poised to Challenge Standard Cancer Treatments in the $3+ Billion Pancreatic Cancer Market
05/02/2026
Pages